Close Menu

NEW YORK – Progenity is seeking a declaratory judgment from a court that the in-house use of its Innatal noninvasive prenatal test and related activities do not infringe six patents held by Natera.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.